Logunov, Denis Y

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Logunov, D. Y., Dolzhikova, I. V., Shcheblyakov, D. V., Tukhvatulin, A. I., Zubkova, O. V., Dzharullaeva, A. S., Kovyrshina, A. V., Lubenets, N. L., Grousova, D. M., Erokhova, A. S., et al. (2021) · The Lancet

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 1,747

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Logunov, D. Y., Dolzhikova, I. V., Zubkova, O. V., Tukhvatulin, A. I., Shcheblyakov, D. V., Dzharullaeva, A. S., Grousova, D. M., Erokhova, A. S., Kovyrshina, A. V., Botikov, A. G., et al. (2020) · The Lancet

SARS-CoV-2 and COVID-19 ResearchVirus-based gene therapy research

Cited by 1,055

Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: an open phase I/II trial in healthy adults in Russia

Dolzhikova, I. V., Zubkova, O. V., Tukhvatulin, A. I., Dzharullaeva, A. S., Tukhvatulina, N. M., Shcheblyakov, D. V., Shmarov, M. M., Tokarskaya, E. A., Simakova, Y. V., Egorova, D. A., et al. (2017) · Human Vaccines & Immunotherapeutics

Viral Infections and Outbreaks ResearchViral Infections and Vectors

Cited by 132

Formatted single-domain antibodies can protect mice against infection with influenza virus (H5N2)

Tillib, S. V., Ivanova, T. I., Vasilev, L. A., Rutovskaya, M. V., Saakyan, S. A., Gribova, I. Y., Tutykhina, I. L., Sedova, E. S., Lysenko, A. A., Shmarov, M. M., et al. (2013) · Antiviral Research

Monoclonal and Polyclonal Antibodies ResearchInfluenza Virus Research Studies

Cited by 54

Interactions between Sulfated Polysaccharides from Sea Brown Algae and Toll-Like Receptors on HEK293 Eukaryotic Cells In Vitro

Makarenkova, I. D., Logunov, D. Y., Tukhvatulin, A. I., Semenova, I. B., Besednova, N. N., & Zvyagintseva, T. N. (2012) · Bulletin of Experimental Biology and Medicine

Seaweed-derived Bioactive CompoundsImmune Response and Inflammation

Cited by 53

A heterologous virus-vectored vaccine for prevention of Middle East respiratory syndrome induces long protective immune response against MERS-CoV

Kovyrshina, A. V., Federal Research Centre of Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya, M. O. H. O. T. R. F., Dolzhikova, I. V., Federal Research Centre of Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya, M. O. H. O. T. R. F., Grousova, D. M., Federal Research Centre of Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya, M. O. H. O. T. R. F., Balyasin, M. V., Federal Research Centre of Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya, M. O. H. O. T. R. F., Botikov, A. G., Federal Research Centre of Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya, M. O. H. O. T. R. F., et al. (2020) · Immunologiya

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 13

Identification of novel 5’ UTR variants for enhanced mRNA translation and vaccine immunogenicity

Mazunina, E. P., Dzharullaeva, A. S., Kleymenov, D. A., Bykonia, E. N., Kozlova, S. R., Usachev, E. V., Panova, E. A., Konopleva, M. V., Telegina, D. V., Kukushkina-Zvezdova, A. A., et al. (2026) · Scientific Reports

RNA and protein synthesis mechanismsRNA Interference and Gene Delivery

Cited by 0